Introduction
Results

a
Mutational landscape of metastatic pheochromocytoma and paraganglioma

Somatic copy-number alteration profile in metastatic pheochromocytoma and paraganglioma
Transcriptomic landscape of metastatic pheochromocytoma and paraganglioma

a
Metastasis risk classifier for pheochromocytoma and paraganglioma
Functional enrichment analysis of mutated and CN-altered genes in metastatic pheochromocytoma and paraganglioma

Immune landscape of metastatic pheochromocytoma and paraganglioma
a
Immunogenomics as a theranostic tool in the immunotherapy contexture of metastatic pheochromocytoma and paraganglioma

a
Discussion
ATRX/TERT
Strategies to individualize immunotherapy based on patient- and tumor-specific characteristics are a current focus of the scientific community67